Segesterone Acetate/Ethinyl Estradiol 12-Month Contraceptive Vaginal System Safety Evaluation

OBJECTIVES: To evaluate the safety outcomes from clinical studies of a 12-month Contraceptive Vaginal System (CVS) releasing an average of segesterone acetate (SA) 150 mcg and ethinyl estradiol (EE) 13 mcg daily. STUDY DESIGN: We integrated clinical safety data from nine studies of the CVS. Four stu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contraception
Main Authors: Gemzell-Danielsson, Kristina, Sitruk-Ware, Regine, Creinin, Mitchell D., Thomas, Michael, Barnhart, Kurt T., Creasy, George, Sussman, Heather, Alami, Mohcine, Burke, Anne E., Weisberg, Edith, Fraser, Ian, Miranda, Marie-José, Gilliam, Melissa, Liu, James, Carr, Bruce, Plagianos, Marlena, Roberts, Kevin, Blithe, Diana
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357828/
https://ncbi.nlm.nih.gov/pubmed/30831102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2019.02.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados